International Cooperation Expanded at CPHI & PMEC China 2026

International Cooperation Expanded at CPHI & PMEC China 2026

From June 16 to 18, 2026, representatives of the Pharm Service State Institution took part in CPHI & PMEC China 2026, an international pharmaceutical exhibition held in Shanghai.

As part of the visit, a series of B2B meetings were conducted with representatives of major Chinese pharmaceutical companies, including Sinopharm, Zhejiang Huahai Pharmaceutical, CATO Research Chemicals, Hisun Pharmaceutical, Guobang Pharma, Jiuzhou Pharmaceutical, and Hisoar Pharma.

The meetings focused on opportunities for entering the pharmaceutical market of Uzbekistan, establishing cooperation with local companies, supplying pharmaceutical products and raw materials, and developing long-term business partnerships.

The companies were also provided with information on the Uzbekistan pharmaceutical market, product registration procedures, GxP requirements, and practical support available for market entry.

These meetings contribute to strengthening direct ties with international pharmaceutical companies, developing new cooperation projects, and supporting their entry into the Uzbekistan market.